The Latest Breaking News from Eli Lilly

Eli Lilly stock jumped Friday after unveiling a nearly $2 billion takeover that could bolster its efforts among weight-loss drugs.

The S&P 500 and Nasdaq led a strong market rally this week as inflation fears wane. Salesforce, Delta Air Lines, JPMorgan were key newsmakers

Observer investigation raises concerns about the influence of drugs companies in shaping patient care in services that use their products

The FDA fully approved Biogen Inc. but there are other companies with treatments in the pipeline

The market rally had a strong week, with the major indexes rebounding toward 2023 highs and many stocks flashing buy signals.

Eli Lilly said Thursday it will buy its diabetes treatment partner, Sigilon Therapeutics, and the biotech stock skyrocketed.

The number of people with dementia, including those with Alzheimer's disease, are projected to increase from 50+ million now to more than 150 million in 2050, according to Alzheimer's Disease International. Those sheer numbers will mean that investors in certain stocks, producing Alzheimer's drugs to combat the disease, are poised…

Eli Lilly stock surged closer to a record high Tuesday after the company set a new bar in the industry for weight-loss medications.

More evidence is needed if the treatment is to be approved for NHS use, England drugs watchdog says